Literature DB >> 20824900

oral bisphosphonate use may protect women from breast cancer.

Rebecca Kirk.   

Abstract

Entities:  

Year:  2010        PMID： 20824900     DOI： 10.1038/nrclinonc.2010.126

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  3 in total

1.  Use of bisphosphonates and risk of postmenopausal breast cancer.

Authors:  Gad Rennert; Mila Pinchev; Hedy S Rennert
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 44.544

2.  Oral bisphosphonate use and breast cancer incidence in postmenopausal women.

Authors:  Rowan T Chlebowski; Zhao Chen; Jane A Cauley; Garnet Anderson; Rebecca J Rodabough; Anne McTiernan; Dorothy S Lane; Joann E Manson; Linda Snetselaar; Shagufta Yasmeen; Mary Jo O'Sullivan; Monika Safford; Susan L Hendrix; Robert B Wallace
Journal:  J Clin Oncol       Date:  2010-06-21       Impact factor: 44.544

3.  Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

Authors:  Michael Gnant; Brigitte Mlineritsch; Walter Schippinger; Gero Luschin-Ebengreuth; Sabine Pöstlberger; Christian Menzel; Raimund Jakesz; Michael Seifert; Michael Hubalek; Vesna Bjelic-Radisic; Hellmut Samonigg; Christoph Tausch; Holger Eidtmann; Günther Steger; Werner Kwasny; Peter Dubsky; Michael Fridrik; Florian Fitzal; Michael Stierer; Ernst Rücklinger; Richard Greil; C Marth
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245
  3 in total
  1 in total

1.  Bisphosphonates and primary breast cancer risk: an updated systematic review and meta-analysis involving 963,995 women.

Authors:  Yupeng Liu; Xiaosan Zhang; Hongru Sun; Shu Zhao; Yuxue Zhang; Dapeng Li; Qingyuan Zhang; Yashuang Zhao
Journal:  Clin Epidemiol       Date:  2019-07-18       Impact factor: 4.790
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.